256 related articles for article (PubMed ID: 35617427)
1. Polycomb-mediated genome architecture enables long-range spreading of H3K27 methylation.
Kraft K; Yost KE; Murphy SE; Magg A; Long Y; Corces MR; Granja JM; Wittler L; Mundlos S; Cech TR; Boettiger AN; Chang HY
Proc Natl Acad Sci U S A; 2022 May; 119(22):e2201883119. PubMed ID: 35617427
[TBL] [Abstract][Full Text] [Related]
2. Polycomb Gene Silencing Mechanisms: PRC2 Chromatin Targeting, H3K27me3 'Readout', and Phase Separation-Based Compaction.
Guo Y; Zhao S; Wang GG
Trends Genet; 2021 Jun; 37(6):547-565. PubMed ID: 33494958
[TBL] [Abstract][Full Text] [Related]
3. An H3K36 methylation-engaging Tudor motif of polycomb-like proteins mediates PRC2 complex targeting.
Cai L; Rothbart SB; Lu R; Xu B; Chen WY; Tripathy A; Rockowitz S; Zheng D; Patel DJ; Allis CD; Strahl BD; Song J; Wang GG
Mol Cell; 2013 Feb; 49(3):571-82. PubMed ID: 23273982
[TBL] [Abstract][Full Text] [Related]
4. Cell reprogramming requires silencing of a core subset of polycomb targets.
Fragola G; Germain PL; Laise P; Cuomo A; Blasimme A; Gross F; Signaroldi E; Bucci G; Sommer C; Pruneri G; Mazzarol G; Bonaldi T; Mostoslavsky G; Casola S; Testa G
PLoS Genet; 2013; 9(2):e1003292. PubMed ID: 23468641
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-323-3p regulates the activity of polycomb repressive complex 2 (PRC2) via targeting the mRNA of embryonic ectoderm development (Eed) gene in mouse embryonic stem cells.
Zhang Y; Teng F; Luo GZ; Wang M; Tong M; Zhao X; Wang L; Wang XJ; Zhou Q
J Biol Chem; 2013 Aug; 288(33):23659-65. PubMed ID: 23821546
[TBL] [Abstract][Full Text] [Related]
6. EZH1 mediates methylation on histone H3 lysine 27 and complements EZH2 in maintaining stem cell identity and executing pluripotency.
Shen X; Liu Y; Hsu YJ; Fujiwara Y; Kim J; Mao X; Yuan GC; Orkin SH
Mol Cell; 2008 Nov; 32(4):491-502. PubMed ID: 19026780
[TBL] [Abstract][Full Text] [Related]
7. CBP-mediated acetylation of histone H3 lysine 27 antagonizes Drosophila Polycomb silencing.
Tie F; Banerjee R; Stratton CA; Prasad-Sinha J; Stepanik V; Zlobin A; Diaz MO; Scacheri PC; Harte PJ
Development; 2009 Sep; 136(18):3131-41. PubMed ID: 19700617
[TBL] [Abstract][Full Text] [Related]
8. The H3K36me2 Methyltransferase Nsd1 Demarcates PRC2-Mediated H3K27me2 and H3K27me3 Domains in Embryonic Stem Cells.
Streubel G; Watson A; Jammula SG; Scelfo A; Fitzpatrick DJ; Oliviero G; McCole R; Conway E; Glancy E; Negri GL; Dillon E; Wynne K; Pasini D; Krogan NJ; Bracken AP; Cagney G
Mol Cell; 2018 Apr; 70(2):371-379.e5. PubMed ID: 29606589
[TBL] [Abstract][Full Text] [Related]
9. Capturing the Onset of PRC2-Mediated Repressive Domain Formation.
Oksuz O; Narendra V; Lee CH; Descostes N; LeRoy G; Raviram R; Blumenberg L; Karch K; Rocha PP; Garcia BA; Skok JA; Reinberg D
Mol Cell; 2018 Jun; 70(6):1149-1162.e5. PubMed ID: 29932905
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide profiling of histone H3 lysine 27 and lysine 4 trimethylation in multiple myeloma reveals the importance of Polycomb gene targeting and highlights EZH2 as a potential therapeutic target.
Agarwal P; Alzrigat M; Párraga AA; Enroth S; Singh U; Ungerstedt J; Österborg A; Brown PJ; Ma A; Jin J; Nilsson K; Öberg F; Kalushkova A; Jernberg-Wiklund H
Oncotarget; 2016 Feb; 7(6):6809-23. PubMed ID: 26755663
[TBL] [Abstract][Full Text] [Related]
11. A central role for G9a and EZH2 in the epigenetic silencing of cyclooxygenase-2 in idiopathic pulmonary fibrosis.
Coward WR; Feghali-Bostwick CA; Jenkins G; Knox AJ; Pang L
FASEB J; 2014 Jul; 28(7):3183-96. PubMed ID: 24652950
[TBL] [Abstract][Full Text] [Related]
12. H3K27me3 spreading organizes canonical PRC1 chromatin architecture to regulate developmental programs.
Krug B; Hu B; Chen H; Ptack A; Chen X; Gretarsson KH; Deshmukh S; Kabir N; Andrade AF; Jabbour E; Harutyunyan AS; Lee JJY; Hulswit M; Faury D; Russo C; Xu X; Johnston MJ; Baguette A; Dahl NA; Weil AG; Ellezam B; Dali R; Blanchette M; Wilson K; Garcia BA; Soni RK; Gallo M; Taylor MD; Kleinman CL; Majewski J; Jabado N; Lu C
bioRxiv; 2023 Nov; ():. PubMed ID: 38116029
[TBL] [Abstract][Full Text] [Related]
13. PcG proteins, DNA methylation, and gene repression by chromatin looping.
Tiwari VK; McGarvey KM; Licchesi JD; Ohm JE; Herman JG; Schübeler D; Baylin SB
PLoS Biol; 2008 Dec; 6(12):2911-27. PubMed ID: 19053175
[TBL] [Abstract][Full Text] [Related]
14. Dissecting the role of H3K27 acetylation and methylation in PRC2 mediated control of cellular identity.
Lavarone E; Barbieri CM; Pasini D
Nat Commun; 2019 Apr; 10(1):1679. PubMed ID: 30976011
[TBL] [Abstract][Full Text] [Related]
15. Polycomb protein EED is required for silencing of pluripotency genes upon ESC differentiation.
Obier N; Lin Q; Cauchy P; Hornich V; Zenke M; Becker M; Müller AM
Stem Cell Rev Rep; 2015 Feb; 11(1):50-61. PubMed ID: 25134795
[TBL] [Abstract][Full Text] [Related]
16. IMITATION SWITCH is required for normal chromatin structure and gene repression in PRC2 target domains.
Kamei M; Ameri AJ; Ferraro AR; Bar-Peled Y; Zhao F; Ethridge CL; Lail K; Amirebrahimi M; Lipzen A; Ng V; Grigoriev IV; Schmitz RJ; Liu Y; Lewis ZA
Proc Natl Acad Sci U S A; 2021 Jan; 118(4):. PubMed ID: 33468665
[TBL] [Abstract][Full Text] [Related]
17. Roles of H3K27me2 and H3K27me3 Examined during Fate Specification of Embryonic Stem Cells.
Juan AH; Wang S; Ko KD; Zare H; Tsai PF; Feng X; Vivanco KO; Ascoli AM; Gutierrez-Cruz G; Krebs J; Sidoli S; Knight AL; Pedersen RA; Garcia BA; Casellas R; Zou J; Sartorelli V
Cell Rep; 2016 Oct; 17(5):1369-1382. PubMed ID: 27783950
[TBL] [Abstract][Full Text] [Related]
18. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.
Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS
J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240
[TBL] [Abstract][Full Text] [Related]
19. Jarid2 Methylation via the PRC2 Complex Regulates H3K27me3 Deposition during Cell Differentiation.
Sanulli S; Justin N; Teissandier A; Ancelin K; Portoso M; Caron M; Michaud A; Lombard B; da Rocha ST; Offer J; Loew D; Servant N; Wassef M; Burlina F; Gamblin SJ; Heard E; Margueron R
Mol Cell; 2015 Mar; 57(5):769-783. PubMed ID: 25620564
[TBL] [Abstract][Full Text] [Related]
20. Polycomb Repressive Complex 2 in Oncology.
Guo Y; Yu Y; Wang GG
Cancer Treat Res; 2023; 190():273-320. PubMed ID: 38113005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
